Lymphadenitis
Showing 1 - 25 of 456
Tuberculous Lymphadenitis Trial in Taipei (Prednisolone, standard anti-tuberculosis agents)
Recruiting
- Tuberculous Lymphadenitis
- Prednisolone
- standard anti-tuberculosis agents
-
Taipei, TaiwanNational Taiwan University Hospital
May 17, 2023
Sinusitis, Otitis, Laryngitis Trial in Ljubljana (Treatment with surgery and/or conservative measures)
Not yet recruiting
- Sinusitis
- +10 more
- Treatment with surgery and/or conservative measures
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Sep 3, 2023
Lymphadenitis, Tuberculous, Immune Defect Trial in Surabaya (Immuno-histochemical staining)
Completed
- Lymphadenitis, Tuberculous
- Immune Defect
- Immuno-histochemical staining
-
Surabaya, East Java, IndonesiaVincentius A Paulo Surabaya Hospital
Jan 8, 2022
Outcomes in Tuberculous Patients in Sohag Governorate
Recruiting
- Tuberculosis
- sputum analysis
- lymph node biobsy
-
Sohag, EgyptSohag university Hospital
Nov 15, 2023
Genetics and Immunology of Periodic Fever, Aphthous Stomatitis,
Not yet recruiting
- Periodic Fever, Aphthous Stomatitis, Pharyngitis, And Cervical Adenitis (Pfapa)
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Diagnosis, Axilla; Breast Trial in Ankara (Ultrasound and biyopsy)
Completed
- Diagnosis
- Axilla; Breast
- Ultrasound and biyopsy
-
Ankara, TurkeyAnkara Education and Research Hospital
Jun 25, 2023
BCG Vaccination Reaction Trial (bcg vaccine)
Not yet recruiting
- BCG Vaccination Reaction
- bcg vaccine
- (no location specified)
Mar 13, 2021
BCG Vaccination Reaction, Tuberculosis Trial (GC3107, Intradermal BCG SSI inj.)
Completed
- BCG Vaccination Reaction
- Tuberculosis
- GC3107
- Intradermal BCG SSI inj.
-
Suwon, Korea, Republic of
- +1 more
Oct 31, 2022
Iron Deficiency Anemia (IDA) Trial in Poland, Russian Federation (Ferric Carboxymaltose (FCM))
Completed
- Iron Deficiency Anemia (IDA)
- Ferric Carboxymaltose (FCM)
-
Bydgoszcz, Poland
- +9 more
Jul 21, 2022
Type 1 Diabetes Trial in San Diego, Edmonton (VC-01™ Combination Product)
Terminated
- Type 1 Diabetes Mellitus
- VC-01™ Combination Product
-
San Diego, California
- +1 more
Feb 25, 2022
Hepatitis C, Chronic, HIV Infection Trial in Hai Phong, Ho Chi Minh City (Raltegravir, Efavirenz)
Completed
- Hepatitis C, Chronic
- HIV Infection
-
Hai Phong, Vietnam
- +1 more
Jul 21, 2021
Death; Neonatal, Death, Infant, Morbidity;Newborn Trial in Bissau (BCG-Denmark, BCG-Bulgaria)
Not yet recruiting
- Death; Neonatal
- +4 more
- BCG-Denmark
- BCG-Bulgaria
-
Bissau, Guinea-BissauBandim Health Project
May 26, 2022
Migraine Trial in Sendai (Each subject will subcutaneously self-administer TEV 48125 at 225 mg/1.5 mL (150 mg/mL) once monthly
Completed
- Migraine
- Each subject will subcutaneously self-administer TEV 48125 at 225 mg/1.5 mL (150 mg/mL) once monthly for a total of 2 doses.
-
Sendai, JapanSendai Zutsu No-Shinkei Clinic
Oct 26, 2021
Heterologous Immunity, Infant Morbidity, Infant Mortality Trial in Bissau (BCG-Japan, BCG-Russia)
Completed
- Heterologous Immunity
- +5 more
- BCG-Japan
- BCG-Russia
-
Bissau, Guinea-Bissau
- +1 more
Dec 13, 2020
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Canada, United States (asparaginase Erwinia chrysanthemi)
Completed
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- asparaginase Erwinia chrysanthemi
-
Los Angeles, California
- +21 more
Jun 1, 2021
HIV Trial in Puerto Rico, United States (Didanosine (ddI), Efavirenz (EFV), Emtricitabine (FTC))
Completed
- HIV Infections
- Didanosine (ddI)
- +2 more
-
San Diego, California
- +17 more
Nov 3, 2021
JARDIANCE® Tablets in Japanese Type 2 Diabetes Mellitus
Completed
- Diabetes Mellitus, Type 2
-
Multiple Locations, Japan(unnamed)
Dec 2, 2021
Periodic Fever, Aphthous Stomatitis, Pharyngitis Trial (Lactobacillus acidophilus and Bifidobacterium lactis, Placebo)
Withdrawn
- Periodic Fever
- +3 more
- Lactobacillus acidophilus and Bifidobacterium lactis
- Placebo
- (no location specified)
Jan 23, 2018
Anemia; Hemodialysis Dependent Chronic Kidney Disease Trial in Japan (MT-6548, Darbepoetin alfa, MT-6548-matching )
Completed
- Anemia; Hemodialysis Dependent Chronic Kidney Disease
- MT-6548
- +3 more
-
Aichi, Japan
- +27 more
Aug 2, 2021
XMEN Trial run by the NIAID (dietary supplement, other, drug)
Completed
- XMEN
- Magnesium L-threonate
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 9, 2022
Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™)
Completed
- Pneumococcal Infections
- V114
- Prevnar 13™
-
Downey, California
- +75 more
Sep 22, 2022